Veracyte

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veracyte and other ETFs, options, and stocks.

About VCYT

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. 

CEO
Marc A. Stapley
CEOMarc A. Stapley
Employees
824
Employees824
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2006
Founded2006
Employees
824
Employees824

VCYT Key Statistics

Market cap
2.89B
Market cap2.89B
Price-Earnings ratio
107.69
Price-Earnings ratio107.69
Dividend yield
Dividend yield
Average volume
797.55K
Average volume797.55K
High today
$37.07
High today$37.07
Low today
$36.15
Low today$36.15
Open price
$36.40
Open price$36.40
Volume
861.65K
Volume861.65K
52 Week high
$47.32
52 Week high$47.32
52 Week low
$22.61
52 Week low$22.61

VCYT News

TipRanks 17h
Veracyte initiated with a Hold at Canaccord

Canaccord analyst Kyle Mikson initiated coverage of Veracyte (VCYT) with a Hold rating and $40 price target The company’s Afirma tests for thyroid nodule classi...

Analyst ratings

83%

of 12 ratings
Buy
83.3%
Hold
8.3%
Sell
8.3%

People also own

Based on the portfolios of people who own VCYT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.